Wyss researchers have created a new class of injectable, adhesive biomaterials poised to become the leading solution for volumetric muscle loss, a condition in which muscles are damaged to the point that their function is permanently compromised, resulting in long-term disability.
Crosslinked biomaterial remains in place despite muscle movements and promotes improved healing after traumatic injury
